©Ê§O»{¦P»Ùê¦X¨Ö¼~Æ{¯g-¤GÓӮ׳ø§i¤Î¤åÄm¦^ÅU
2000/10/30 ¼ï«Ø§ÓÂå®v
«e¨¥:¦Wµü¸ÑÄÀ
©Ê§O»{¦P»Ùê(GID, Gender Identity disorder )¦bDSM-IVªº©w¸q¤¤¥]§t¥|¶µ·Ç«h1)±wªÌ±j¯P¦Ó«ùÄò¦a»{¦P²§©Êªº©Ê§O¡A§Y·Q¦¨¬°²§©Ê©Î°í«ù¦Û¤w¬O²§©Ê¡A¥B¦¹»{¦P¨Ã¤£¬O¦]¬°¨ä¤å¤ÆI´º¨¬°²§©Ê¯à±o¨ì§Q¯q2)±wªÌ¹ï¦Û¤wªº©Ê§O·Pı·Ð´o¡A©Î¹ï¦Û¤wªº©Ê§O¨¤¦â·Pı¤£¾A·í3)±wªÌ¦b¨Åé¤W¤£Äݩ󳱶§¤Hªº±¡ªp4)±wªÌ¦]©Ê§O»{¦P¦ÓÄY«§xÂZ¡A¨Ã¦]¦¹¦bªÀ·|¤Î¾·~¥\¯à³y¦¨·l®`¡C±wªÌ»{¦P²§©Êªº©w¦ì©M¨¤¦â¡A¥]¬A¦bªA¸Ë¡A¤é±`¦æ¬°µ¥¡CGID¤¤³ÌÄY«ªº±wªÌ¡A¦bDSMIII-R¤¤´¿³Q©R¦W¬°Åܩʼ¤(Transsexualism)¡A¦¹Ãþ±wªÌ¬Æ¦ÜÄ@·N±µ¨üÅܩʤâ³N(DSMVI)¡C
¬y¦æ¯f¾Ç
©Ê§O»{¦P»Ùê¬O¤@ºØ¨u¨£ªº¯e±w¡A«O¦u¦ôp¦b^°ê¤¤34,000¦W¨k©Ê¡A¥H¤Î108,000¦W¤k©Ê¦³¦³¤@¤H±w¦³¦¹¯g(Hoeing & Kenna 1974)¡C²üÄõ«h¨k¥Í¦b1,1900¤H¤¤¡A¤k¥Í¦b30,400¤H¤¤¦³¤@¤H±w¦³¦¹¯g¡A¦ý¾Ú¦X²zªº±ÀÂ_¨ä²±¦æ²v¥i¯à§ó°ª¡C¥xÆW®Ú¾ÚJµ¥¤Hªº²Îp¡A1989¦~18·³¥H¤Wªº¤H¤f¤¤Åܩʼ¤ªº²±¦æ²v¬°0.097%¡A¨k¥Íªº²±¦æ²v¬ù0.013%¡A¤k¥Í¬ù0.19%¡A¤]´N¬O¥Ø«e¨k¥Í¬ù¦³2990¦W¡A¤k¥Í¬ù¦³44333¦W¦¹Ãþ±wªÌ¡C¦Ó¾Ú¤åµ¥¤Hªº²Îp¡A1979¦~¦Ü1989¦~¶¡n¨D¶i¦æÅܩʤâ³Nªº¨k¤k¤ñ²v¤j¬ù¬O 1:1.5¡A¥t¾Ú§õµ¥¤Hªº²Îp 1979¦~¶¡¦Ü 1985¦~¶¡n¨D¶i¦æÅܩʤâ³Nªº¨k¤k¤ñ²v¤j¬ù¬O 1:3.5©M°ê¥~¤k¦h©ó¨kªº±¡ªp¤£¦P¡A¥i¯à¬O¥xÆW¤´³B©ó«¨k¸g¤kªºªÀ·|¦³Ãö¡C
ÁöµMDSM¶EÂ_¨t²Î©óDSMII§Y¶}©l¸ü©ú¦¹¯e±w¡A¦ý¦h¼Æ±wªÌ¹ï¤£»{¦P¦Û¤w¦³ºë¯«¬ì¤è±ªº¯e¯f¡A¦ýºë¯«¬ìÂå®vªºµû¦ô¡A¥Ø«e³Q¼sªx±µ¨ü¦¨¬°¶i¦æÅܩʤâ³N(SRS, sex-reassignment surgery)«e¤§¥²n±ø¥ó¡Cºë¯«¬ìÂå®v°£¤Fµû¦ôӮ׬O§_¾A¦X±µ¨üÅܩʤâ³N¤§¥~¡A¥²n®É¤]¥i¥H´£¨Ñ¨ó¦PªvÀø¡A¦b¤â³N«e©Î¤â³N«áµ¹¤©ÃĪ«©Î¤ß²zªvÀø¡C¥»¤å¥Øªº¦b©ó§e²{2.5¦W¦~»´ªº©Ê§O»{¦P»Ùê±wªÌ¡A¥X²{¼~Æ{±¡ºü¤Î¦Û±þ·N©À¦Ó¦Üªù¶E¨D¶E¤§ªvÀø¸g¹L¡C
Ӯ׳ø§i:Ӯפ@
16·³¨k©m¡A¥¼±B¡A®a¤¤¤l¤k±Æ¦æ²Ä¤G¡A¦³ôô¤Î©f©f¡C¥Ñ¤÷¥À³¦P«e¨Ó¦Üªù¶E¨D¶E¡A¥D¶D¬°±¡ºü§C¸¨¡A¥¢¯v¤Î¦Û±þ·N©À¡C
Ӯפ÷¥À¨Ãn¨DÂå®vµû¦ô¨Ã¨ó§U§ïµ½¨äÅܩʤ§©ÀÀY¡CÓ®×¥~ªí²M¨q½G®z¡A¯dªø¾v¡A§e¤¤©Ê¤Æ¤§¥´§ê¡C¥Ø«e¥¼´N¾Ç¡A¤]¨S¦³¤u§@¡Cªì¶E®ÉºA«×¨HÀq¹è¨¥¡A¹ï·|½Í¤£§ë¤J¡A¦^µª°ÝÃD¦h²µu¦ÓÁU½k¡C
¾Ú¤÷¥À©Ò¨¥¡AÓ®×¥X¥Í«á2Ӥ봿¦]¤£©úì¦]¥X²{»Ä¤¤¬r²{¶H¡A¦b¤G·³¥ª¥k´¿¸g¦]·Ä¤ô¦Ó¥¢¥h·NÃÑ¡A«á¨Ó«æ±Ï¦s¬¡«á¥X²{µo»y¨¥µo®i¿ð½w²{¶H¡Aª½¦Ü¥|·³®É¤~¾Ç·|¨Ï¥Î¥y¤l¡A¦]¦¹´¿±µ¨ü»y¨¥ªvÀø¡A¥Ø«e¯f±w¤´¦³»´·Lºcµ»Ùê¡A¦ý©M¥L¤H·¾³q¨S¦³°ÝÃD¡C
Ӯצ^¾Ð¬ù¤Q·³¥ª¥k¶}©l¹½´c¦Û¤w¬O¨k¥Íªº¨Åé¡A³ßÅw°Ñ¥[¤k¥Íªº¹CÀ¸, ¾\Ū¤Ö¤kº©µe¡A·í®É´¿°½¬ï¶ý¶ýªº¦çªA¡A¦]¦¹¼Æ«×³Q®a¤Hµo²{¦Ó¾DÄY¼F¥¸³d¡CӮצ^¾Ð¦b¤p¾Ç¤T¦~¯Å®É±µ¨üӮդ߲z´úÅ礧¦Û¶ñ°Ý¨÷½Õ¬d¡A¦^µª¦Û¤w¦b¤ß²z¤W¸û¬°¶É¦V±µ¨ü¤k©Ê¨¤¦â¡A¦ý·í®É¥¼©M±M·~¤Hû¦³ªñ¤@¨B±µÄ²¡C
Ӯװꤤ¤@¦~¯Å®ÉÀH¤÷¿Ë¤½·Fu¬ü¡A´NŪ©ó¬ü°ê¤¤¾Ç¡A·í¦a®Õ·«O¦u¡AӮפ´µM¥²»ÝÁôÂæۤwªº©Ê¶É¦V¡C·í®É´¿·tÅʤ@¦ìª÷¾v¨k¦P¾Ç¡A¦ýӮר䣴±¦³¶i¤@¨Bªºªí¥Ü¡AӮתí¥Ü·í¤wı±o¦Û¤wÁöµM¨Å馳¬O¨k©Ê¯S¼x¡A¦ý¤ß²z¤W¬O¤k¥Í¡A©Ò¥H³ßÅw¨k¥Í¬O¥¿±`ªº¡C°ê¤¤¤T¦~¯Å¤§«á¡AӮץѾǮպô¸ô¤W±oª¾Åܩʤâ³N¤§¬ÛÃö²Ó¸`¡A¶}©l¦V®a¤Hªí¹F§Æ±æ±µ¨üÅܩʤâ³N¤§¼¤±æ¡A·í®É®a¤H´¿±a¯f±w¦Ü¦a¤j¾ÇÂå¾Ç°|ªþ³]Âå°|ºë¯«¬ì¨D¶E¡Aµû¦ô«á¶EÂ_¬°Åܩʼ¤¡A¸gÂå®v»¡©ú«á®a¤H¤Q¤À¾_Åå¡A¦]¦¹¥¼«ùÄò±a¯f±w«e©¹¨D¶E¡C
Ӯשó¥h¦~ÀH®a¤H¦^°ê¡Aì¥i´NŪ°ª¤¤¡A¦ýӮשڵ´¤W¾Ç¡A²z¥Ñ¬O¦b¾Ç®Õ¤¤¡AÓ®×¥²¶·¥H¨k¥Íªº¨¥÷¥X²{¡A¥BÓ®×µLªk§Ô¨ü¯dµu¾v¤Î¬ï¨k¥Í¨îªA¡C¤÷¿Ë¦]¤u§@Ác¦£¡A¤@ª½¥H¨Ó©MÓ®×±µÄ²®É¶¡´N«Ü¤Ö¡A°¸¦Ó¥æ½Í¡A¤]¦] ¹ïӮפk©Ê¤Æªº¬ïµÛ¤Î·QªkµLªk±µ¨ü¦Ó®É°_¨¥»y½Ä¬ð¡CӮשM¥À¿Ë¸û¬°±µªñ¡A¥À¿ËÁö¤£µM±µ¨üÓ®×·QÅܩʷQªk¡A¦ý¹ï¨ä¤¤©Ê¥´§ê¸û¯à®e§Ô¡CÓ®×¹L¥h©M¤jô¸û¿Ëªñ¡A¥i¥HµL¸Ü¤£½Í¡A¦ý¨ä¥S¨â¦~«e¤w¦Ü¥~°ê¨D¾Ç¡CӮתñ¤@¦~¨Ó¥X²{¼~Æ{±¡ºü¡A¥¢¯v¡AÅ髤U°¡Aª`·N¤O¤£¶°¤¤µ¥¯gª¬¡A¦Û¼J¬O¦ÌÂΡA¹ï¥¼¨Ó·Qªk¤Q¤À´dÆ[¨Ã¥B°hÁY®a¤¤¡AµL¤u§@©Î¨D¾Ç°Ê¾÷¡A©M¹L¥hªB¤Í¤]¨S¦³¨Ó©¹¡CºîÆ[¥H¤W¯gª¬¡A¯f±w²Å¦XDSMVI¤¤«Æ{¯g¶EÂ_¡A¦X¨Ö¦³©Ê§O»{¦P»Ùê¡CӮשM¥~¬É±µÄ²ªº°ß¤@¤è¦¡¬O¥H¥H¤k©Ê¤Æ¦W¤Î¨¥÷¦bºô»Úºô¸ô¤W»{ÃѺô¤Í¡A¨Ã¥H¤k©Ê¨¥÷©M¨k©Êºô¤Í¬ù·|¡A¥Ñ©óӮתº¤k©Ê¤Æ¥~Æ[¤Î©Ê®æ¡Aºô¤Í¤]»{¬°Ó®×¬°¤k©Ê¡CӮרå¼´¿¦³¹L¥ô¦ó«¬¦¡¤§©Ê±µÄ²¡A¦ý©Ó»{¹ï¨k©Ê¦³©Ê¤Û·Q¡C
Ӯצbªù¶E¤¤±µ¨üfluoxetine 20mg /qd ªvÀø¡A¨Ã¦w±Æ¨C©P¤@¦¸¦@12¦¸¤§Ó§O¤ß²zªvÀø¡AªvÀø¤è¦¡¬°¤H»ÚÃö«Y¾É¦V¡A¦b´L«¯f±wªº©Ê§O»{¦P«e´£¤U¡A¥Øªº´î»´¨ä¼~Æ{±¡ºü¤Î¦Û±þ·N©À¡A ¨Ã¹ï¨ä©Ê§O»{¦P»Ùê«ùÄòÆ[¹î»Pµû¦ô¡C¤§¤¤¨Ã¦w±Æ®aÄÝ·|½Í¡A¹ªÀy¥H¦æ¬°¥æ´«ªº¤è¦¡´î»´Ó®×©M®a¤H¶¡ªº½Ä¬ð¡CӮצb¤ß²zªvÀøªì´Áªí²{¥X©úÅ㪺ªý§Ü²{¶H¡A´¿¸g¿ð¨ì¤Î¥¢¬ù¡AªvÀøªÌ§ï±Ä¸û¬°¥D°Ê¿n·¥ªºªvÀø¤è¦¡¡A¸g¹L¼Æ¦¸·|½Í¡A«Ø¥ßÃö«Y«á¯f±w³vº¥¥i¥H§ë¤JªvÀø¡CªvÀø¹Lµ{¤¤¡AªvÀøªÌªí¥ÜªvÀø¤TÓ¤ë«á¼~Æ{±¡ªp§ïµ½¡A¯f±w¤w¤£¦A¦³¦Û±þ·N©À¡C¯f±w¸g¹L¥b¦~¤§ÃĪ«¤Î¤ß²zªvÀø«á¡A¯f±w©Ê§O»{¦PÁöµM¥¼§ïÅÜ¡A¦ý¤w¤£¦A°í«ù¥u¦³Åܩʤâ³N¬O°ß¤@ªº¸Ñ¨M¤èªk¡A¯à¥H¸û²{¹êªº¨¤«×±¹ï¥Ø«eªº§x¹Ò¡C¥»¤åµoªí«e¡AӮשM®a¤H¨ú±o¦@ÃÑ¡A¤wu¬ü¦Ü¾Ç·¸û¬°¶}©ñ¤§ªF©¤·Ç³Æ§¹¦¨°ª¤¤¾Ç·~¡A¨Ã¦P·N¦b·í¦aÄ~Äò±µ¨üºë¯«¬ì¤§°lÂܤΪvÀø¡C
ӮפG
23·³¡A¥¼±B¡A¤w±µ¨üÅܩʤâ³N¥Ñ¤k©ÊÂର¨k©Ê¡A®a¤¤±Æ¦æ²Ä¤G¡A¦³ôô¤Î©f¡A§Ì¡CӮ׸gÂश¦Üªù¶E±µ¨ü¤ß²zªvÀø¡A¥D¶D¬°µJ¼{¡Aªq³à¡AµL±æ·P¤Î¦Û±þ·N©À¡C
¾ÚӮשҨ¥¡A©ó5·³¥ª¥k¶}©lı±o¥Í¿ù©Ê§O¡A¤w¸g¥X²{Åܩʤ§·Qªk¡A²Ä¤@¦¸¬Ý¨£¨k©Ê¤§¥Í´Þ¾¹¡A¤ßùØ·Q¦Û¤w¤]n¤@¼Ë¡C¦Û¥®®É¦æ¬°Á|¤î¨k©Ê¤Æ¡A®a¤¤²ßºD¥H¡i¤Ö·Ý¡jºÙ©I¡AӮצۥ®¤£³ßÅw¤k¸Ë¡A¤]±q¨Ó¤£¬ï¸s¤l¡C«C¤Ö¦~®ÉÓ®×Åܩʤ§·N©À§ó±j¯P¡A¶}©l°l¤k«Ä¤l¡CÓ®×ı±o¦Û¤w¬O¨k©Ê¡A¦]¦¹¤£»{¦Û¤w¬O¦P©ÊÅÊ¡A¤Ï¦Óı±o¦P©ÊÅʬO¥i®¢ªº¦æ¬°¡A¦P¾ÇÁöµM²ßºDӮפ§¨k©Ê¤Æ¦æ¬°¡A¦ýӮפ´µM¦³±¡ºü»Ùê¡A°ª¤¤®É´¿¥X²{©úÅ㤧¼~Æ{¯gª¬¡A¨Ã¦³¦Û±þªº©ÀÀY¡CÓ®×°ª¤¤²¦·~«á¡A¤÷¿Ë¹ïÓ®×´¿¸gu¤j³°´M¨DÅܩʤâ³NªvÀø¦ý¥¼ªG¡C¤§«á¦Ü¥x¥_¬YÂå¾Ç¤¤¤ß§U¡A¸g¹L¨â¦ìºë¯«¬ì±M¬ìÂå®v¤§µû¦ô¤Î°lÂܪvÀø«á¡A©ó21·³?±µ¨üÅܩʤâ³N¡C§ï¦W¤Î¨¥÷µý¡C
Ӯפâ³Nµ²ªG¨}¦n¡AÄ~Äò±µ¨üºë¯«¬ì¤§°lÂÜ¡C¦ý©ó25·³®É¥X²{¾AÀ³¤£¨}¤Î¼~Æ{¯gª¬¡C¥]¬A¼~Æ{¤ß±¡¡AµL¤O·P¡AµL§U·P¡AµJ¼{¡A°hÁY¡Aª`·N¤O¤£¶°¤¤¡A¸o´c·P¤Î¦Û±þ·N©À¡CÂå®vµ¹¤©fluoxetine 20mg /qd ªvÀø¡A¨Ã¦w±Æ¨C©P¤@¦¸¦@16¦¸¤§Ó§O¤ß²zªvÀø¡C
ӮפT¡A21·³¡A¨k¦V¤k©ÊÅܩʼ¤±wªÌ¡A¥ç¦X¨Ö¥X²{¼~Æ{¯g¡A¦³¨â¦¸¦Û±þ¥¼¹E¡A©Ê¼¤¹ï¦V¬°¤k©Ê¡A¥Ø«e¤´¦bªvÀø¤¤¡C
°Q½×:
A.¥»¤å©ÒzªºÓ®×¡A§¡²Å¦XDSM-IV¤§©Ê§O»{¦P»Ùê¡Ca.±j¯P¦Ó«ùÄò¦a»{¦P²§©Êªº©Ê§O¡AB.¹ï¦Û¤w¤õ¥Íªº©Ê§O·P¨ì§xÂZc.«D³B©ó³±¶§¤Hªºª¬ªpD.¦b«n¥\¯à¤W³y¦¨·l®`¡C¦b§Î¦¨Åܩʼ¤ªº¦MÀI¦]¤l¤è±¡A¥Ñ¯f¥v¤¤¥i¤F¸Ñcase 1 ¤÷¤l¤§¶¡¦¦~ªºÃöÁp¸û¤Ö¡A¦Ócase2 ¨àµ£´Á¹ïÅܩʦ欰¨Ã¨S¦³¤Ó¤jªºÄþ³d¡A¥i¯à¬°¨ä¦¨¦]¤§¤@¡C¥»¤å©ýz¤Îªº¨âÓөʦb¨àµ£®É´Á«KÅãÅS¥X©Ê§O»{¦P»Ùê¡A¨Ã«ùÄò¦Ü«C¤Ö¦~¤Î¦Ü©ó¦¨¦~¡A¥B¶É¦V©ó¦P©ÊÅÊ¡C
B.Ų§O¶EÂ_
1.
nonconformity to
stereotypical sex rale behavior
2.
§Y
Tomboyishness ©Î sissyish¡Agidªº±wªÌ¦b»{¦P±æ¡A¿³½ì¤Î¦æ¬°¤è±§ó±j¯P
3.
paraphilia
--transvestic fetishism §ê²§©ÊÅʪ«Â}--ÅܸˮɷQ¹³¦Û¤w¬O²§©Ê«ÈÅé¡A¬ïµÛ¦¹Ãþ¦çª«¶i¦æ¦Û¼¢©Î©Ê¦æ¬°¡AÂǦ¹¹F¨ì°ª¼é¡C(¹L¥h©ý¿×¤§°²©ÊÅܩʼ¤)·¥¤Ö¼Æ¦¹Ãþ±wªÌ¤]¦³¥i¯àn¨D²üº¸»XªvÀø©ÎÅܩʤâ³N¡C¤j¦h¼Æ§ê²§©ÊÅʪ«Â}¨ÃµL¦X¨Ö©úÅ㪺¨àµ£´Á»{¦P²§©Ê¤§¯f¥v¡C¦ý¨âªÌ¥i¦X¨Ö¶EÂ_¡C
4.
¥ý¤Ñ©Ê³±¶§¤H¡A¦p¶¯¿E¯À¤£±Ó·P¯g©Î¥ý¤Ñ©ÊµÇ¤W¸¢¼W¥Í¯g¡C
5.
¤Ö¼Æªººë¯«¤Àµõ¯g¡A¦h«¤H®æ±wªÌ¡C
¤@¯ë¦Ó¨¥¡A¤j¦h¼ÆªºÅܩʼ¤±wªÌ¨Ã¨S¦³¥²n±µ¨ü¬V¦âÅéÀˬd(DSMVI)
C.¦³Ãö©ó¤Ñ¥Í©Ê§O¡A©Ê§O»{¦P¡A©Ê¨ú¦V¤è±:
¤Ñ¥Í©Ê§O¬°¨k
|
|
©Ê§O»{¦P¬°¨k |
©Ê§O»{¦P¬°¤k |
|
©Ê¨ú¦V¬°¨k |
¦P©ÊÅÊ |
GID¨È«¬1(case1) |
|
©Ê¨ú¦V¬°¤k |
¤@¯ë±¡ªp |
GID¨È«¬2(case3) |
|
©Ê¨ú¦V¬°¨k¤k§¡¥i |
Âù©ÊÅÊ |
GID¨È«¬3 |
|
¹ï¨k¤k³£¤£·P¿³½ì |
hypoactive sexual disorder |
GID¨È«¬4 |
¤Ñ¥Í©Ê§O¬°¤k
|
|
©Ê§O»{¦P¬°¤k |
©Ê§O»{¦P¬°¨k |
|
©Ê¨ú¦V¬°¤k |
¦P©ÊÅÊ |
GID¨È«¬1¦¹«¬³Ì¦h(case2) |
|
©Ê¨ú¦V¬°¨k |
¤@¯ë±¡ªp |
GID¨È«¬2¤Ö¨£ |
|
©Ê¨ú¦V¬°¨k¤k§¡¥i |
Âù©ÊÅÊ |
GID¨È«¬3¤Ö¨£ |
|
¹ï¨k¤k³£¤£·P¿³½ì |
hypoactive sexual disorder |
GID¨È«¬4¤Ö¨£ |
D.Åܩʼ¤¶EÂ_¶i¤J¤½¦@½×zªº¾ú¥v:°ª«×¬Fªv¤ÆªºÂå¾ÇijÃD:
1.Åܩʼ¤±wªÌ¡A³Ì¦¨ü¨ì¤j²³ª`¥Ø¬O¦b1952¦~¡AGeorge JorgensenÅܩʦ¨¬° Chirtine Jorgensen
2.In 1951 George
Jorgensen, an American man of 26, left for Denmark and returned a year later as
the first world-renowned transsexual, Christine Jorgensen. In her own
personable style, Jorgensen offers a firsthand account of her ground-breaking
life. "Nature made a mistake," she wrote, "which I have
corrected."
3.1966¦~ Harry Benjamin¥Xª©®ÑThe TRANSSEXUAL PHENOMENON¨Ã¦¨¥ß°òª÷·|
4.¦P¦~ John Hopkins Hospital¶}©l¬I¦æSRS¡A¤§«á³\¦hÂå¾Ç¤¤¤ß¸ò¶i
5.1980¦~ DSM-III©l¦C¤JÅܩʼ¤¤§¶EÂ_¡C
E.ªvÀøì«h:
¥Ñ©ó²o¯A¨ì³\¦h¶EÂ_¡A¦¨¦]¤ÎÂåÀøÛ²z¤WªºÃøÃD¡AÃø¥H§Î¦¨´¶¹M©Êªº¦@ÃÑ©M³B²zì«h¡C¥Ø«e¥HHarry Benjamin International gender dysphoria association:The
standards of care for gender identity disorderªºì«h¼sªx©Ò±Ä¥Î¡C
ì«h¦p¤U:
1¡D¥Ñºë¯«¬ìÂå®v¶EÂ_¬°GID¡A¾ÚDSM VI©ÎICD10¨Ã±Æ°£¨ä¥¦¶EÂ_
2¡DµøÓ®×ªº±¡ªp¶i¦æ¤ß²zªvÀø¡A©Î®a±ÚªvÀø¡C¯S§O¦bӮפp©ó12·³®É¡A¤£¯à¶i¦æ¥H¤U¤TºØÀøªk¡A¤ß²zªvÀø¼È®É¬O°ß¤@¥i¦æªº¤¶¤J¤è®×¡C
3¡DReal life experience¡A¯u¹ê¥Í¬¡ÅéÅç:ÅýÓ®×¥H¥t¤@©Ê¨¤¦â¥X²{¡AÆ[¹î¨Ã¨ó§U¨ä¾AÀ³¤u§@¡A½Ò·~¤Î¤H»ÚÃö«Y¡C
«C¤Ö¦~¥i¥H¶i¦æReal life
experience
4¡DHormone Therapy ¡A¥²»Ý¦¨¦~©l±o¶i¦æ¡A¥Bn¦³3 Ӥ몺Real life experience¡A¥H¤Î¬Û·í®É¶¡ªº¤ß²zªvÀø©MÆ[¹î´Á¡C¦]¦¹¤º¤ÀªcÂå®v¥²»Ýn¦³¤@«Êºë¯«¬ìÂå®vªºµý©ú¯à¶i¦æH/T
¨k©Ê:µ¹¤©antiandrogen¤ÎLHRH agonist--´î¤Ötesteroneªº¤Àªc
¤k©Ê::µ¹¤©androgen,progestins,©MLHRH agonist--´î¤Öestrodil,estrone,progestroneªº¤Àªc
5.Sex Reassignment
surgery(SRS)
¥²»Ý¦¨¦~¡A¥Bn¦³¤@¦~¥H¤WªºReal life experience¤Î¤@¦~¥H¤WªºHormone Therapy¡A¨Ã¥B¸g¹L¨âÓ¤£¦P¤¤¤ßªººë¯«¬ìÂå®vµû¦ô¨Ã¥X¨ãµý©ú¡A¤è¥i¬°¤§¡C
|
|
|
F.ªvÀøªºì«h°Q½×
1.
¹ï©ó©Ê§O»{¦P»Ùê±wªÌ¬O§_n´£¦¶i¦æSRS¤â³N¡A¤ñ¤è¦b«C¤Ö¦~®É¶i¦æ¡A¥H¨ó§U¨äµo®i¡A¥Ø«e¬Ýªk¤£¤@¡C
2.
DSM-VIªº©w¸q¬°¤@¸s²§½è©Êªº¹ÎÅé¡A¥]§t¨àµ£¤Î¦¨¤H¤Î¤ÀÃþ¡A¦ý¹ï¦óºØÓ®×¾A¦X±µ¨üªvÀø«hµL¼vÅT¡C
3.
ture
transexsualism¤§·§©À¤w´±ó¡ADSMVI¥i±µ¨ü¦X¨Ö¤§¶EÂ_¡C
4.
¨M©wn¤£n¤â³N¡AÀ³¥H¾úµ{¦Ó«D¶EÂ_§O¨M©w¡C
5. SRS¹w«áªºcontrol study¥Ø«e¤´µM«Ü¤Ö¡C
Br J Psychiatry 1990 Aug;157:261-4:A controlled study of psychological and
social change after surgical gender reassignment in selected male
transsexuals.:µ²½×¬O¤ñ¹ï·Ó²Õn¨Óªº¦n¡C
6.
¦X¨Ö¼~Æ{¯g¤§Ó®×À³¿n·¥±µ¨ü¤ß²z©MÃĪ«ªvÀø¡A¨ä°Æ§@¥Î¸ûSRS ©Î HRT¤Ö¦h¤F¡C
7.
Åܩʼ¤¤§¦¨¦]¤£¦] SRS¦Ó®ø¥¢
G.¦X¨Ö¥X²{¼~Æ{¯g¡C
1.©Ê§O»{¦P»Ùê±wªÌ¨®¬ù¦³17%-20%¥X²{¦Û±þ¦æ¬°¡A¥Ñ©ó¦b¹L¥hºë¯«¬ìªvÀøµLªk§ïÅܦ¹¯g¡A¦]¦¹¦³¤H´£¥X¥HÅܩʤâ³N´î¤Ö¦¹¯g±wªÌ¤§¦Û±þ¾÷²v¡C¦ý¾Ú¼ÆÓÅܩʤâ³N«á°lÂܳø§i©ÒÅã¥Ü¡A¦¹¯g±wªÌ¦b³N«á¤´¦³5%-16%¤§¦Û±þ¾÷²v¡C¨¬¨£±µ¨üÅܩʤâ³N¨Ã«D¸Ñ¨M¦¹¯g¤§°ß¤@¤èªk¡A¨¬¨£¦¹¯g±wªÌ¤£½×¬O§_±µ¨üÅܩʤâ³N¡A¤´»Ýªø´Á±µ¨üºë¯«¬ì¤§°lÂܪvÀø¡C
2.Nervenarzt 1998
Sep;69(9):799-805¡A[Results
of long-term follow-up of transsexual patients].¡ARauchfleisch Uªºfallow up ¤¤:
17¦ì¼w°êªºÅܩʤH¦b±µ¨ü¤â³N«á¡A°lÂÜ5-20¦~ªºµ²ªG:
¦³9¦ì»Ý¨Ì¿àªÀ·|ºÖ§Q¬Fµ¦¹L¬¡¡C
¦³8 ¦ì§¹¥þµLªk±o¨ì©Ê§Ö·P¡C
¦³10¦ì¦X¨Ö¥X²{¼~Æ{¯g¡AµJ¼{¯g¤Îª«½èÀݥΡC
¦³2¦ì±µ¨ü¦AÅܩʤâ³N¡C
3.Åܩʼ¤±wªÌ¤§¤ß²zªvÀøì«h:
Expressive
Psychotherapy with gender dysphoric patients
Leslie M. Arch Gen
Psychiatry 1981;38:924-929
1)
³]¥ß²{¹ê¥Ø¼Ð¡C
2)
ªvÀøªÌªº¥D°Ê¡A¤Þ¾É¡A±½è¡A¤ä«ù¡A¼u©Ê¡A«D§PÂ_¡A¬ã¨s©Ê¡C
3)
¨Ï¥ÎÂå®vªº¸ê·½¨Ó±±¨î¯f±wªº¼~Æ{¡A¦Û±þ¡A¤Î½Ä°Ê¦æ¬°¡C
4)
¸ÑÄÀ±`¬°ªvÀø¤¤¤ß¤§¤Ï²¾±¡¡C
5)
¥[¤J©M¯f±wÂù¦V¹ï¸Ü¡A¨Ã¤Þ¾É¯f±w¡C
6)
¤F¸Ñ¤£¦P¥Í©R®É´Á¹ï¯f±wªº¼vÅT¡C
7)
Á×§Kª½±µ±½è¡A©ñºC¸ÑªR¡C
8)
¤F¸Ñ¿ð¨ì©M¥¼¨ì¶E¬O¯f±w¨¾½Ã«ÈÅéÃö«Yªºµ²ªG¡A¨Ã¦b¶}©l®É±µ¨ü¨ä¬°¯f±w¯e¯f¦æ¬°¤§¤@³¡¥÷¡C
9)
°¸¦Ó´£¨ÑÅܩʤâ³N¡Ahormone¤§±Ð¨|°T®§Åý¯f±wµÎ¸Ñ¼¤±æ°Ê§@¤Æ¡C
10)
¤£n§ðÀ»¯f±w©M¦Yhormones©Î¥h¤òªº¦æ¬°¡C
11)
°£«D±wªÌ¬Oºë¯«¤Àµõ¯g±wªÌ¡A§_«h¤£n§âÅܩʤ§¼¤±æ¬Ý¦¨¬O¦k·Q¡C
-
--§¹!ÁÂÁ±zªº@¤ß¾\Ū!